Maiorino, Maria Ida http://orcid.org/0000-0003-4659-7546
Buzzetti, Raffaella http://orcid.org/0000-0003-1490-6041
Irace, Concetta http://orcid.org/0000-0001-5182-5473
Laviola, Luigi http://orcid.org/0000-0001-8860-5845
Napoli, Nicola http://orcid.org/0000-0002-3091-8205
Pitocco, Dario http://orcid.org/0000-0002-6220-686X
Esposito, Katherine http://orcid.org/0000-0002-3652-5154
,
Article History
Received: 6 May 2023
Accepted: 25 July 2023
First Online: 7 September 2023
Change Date: 31 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12020-023-03635-w
Compliance with ethical standards
:
: M.I.M. received speaker fees from Novo Nordisk and Ely Lilly. R.B. received fees from Medtronic, Abbott, Novo Noridsk, Ely Lilly, Astrazeneca and Boehringer Ingelheim Pharmaceuticals. C.I. has provided advisory board services for Novo Nordisk, Lilly, Abbott, Menarini, Ascensia, and Senseonics, and has received speaker fees for Novo Nordisk, Abbott, Ascensia, Lilly, and Boehringer Ingelheim Pharmaceuticals. L.L. has received speaker fees from Abbott, Astra Zeneca, Eli Lilly, Medtronic, Menarini, Novo Nordisk, Roche Diabetes Care, Sanofi Aventis and Terumo and has provided advisory services to Abbott, Eli Lilly, Novo Nordisk, Roche Diabetes Care, and Sanofi Aventis. N.N. received fees from Eli Lilly and Novo Nordisk. K.E. received speaker fees from Novo Nordisk and Ely Lilly and has provided consultancy services to Roche and Medtronic. D.P. has nothing to disclose.